Editorial: Calcium and pulmonary hypertension.
作者信息
Li Ji-Feng, Chen Yu-Qin, Wang Lan, Cao Yun-Shan, Yuan Jason X-J
机构信息
Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
出版信息
Front Physiol. 2022 Nov 3;13:1019158. doi: 10.3389/fphys.2022.1019158. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Calcium and pulmonary hypertension.社论：钙与肺动脉高压
Front Physiol. 2022 Nov 3;13:1019158. doi: 10.3389/fphys.2022.1019158. eCollection 2022.
2
Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.肺动脉高压患者的尼卡地平急性血管反应性测试。
J Pharmacol Sci. 2012;120(3):206-12. doi: 10.1254/jphs.12114fp. Epub 2012 Oct 30.
3
Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.西地那非与一氧化氮用于肺动脉高压急性血管扩张试验的比较
Pulm Circ. 2015 Jun;5(2):305-12. doi: 10.1086/680355.
4
Pulmonary Vascular Capacitance is Associated with Vasoreactivity and Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension.肺血管容量与特发性肺动脉高压患者的血管反应性及对钙通道阻滞剂的长期反应相关。
Lung. 2016 Aug;194(4):613-8. doi: 10.1007/s00408-016-9905-0. Epub 2016 Jun 7.
5
HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.土耳其的HYT高血压：关于单独使用钙通道阻滞剂或与其他抗高血压药物联合使用时血压控制情况的横断面调查
High Blood Press Cardiovasc Prev. 2015 Jun;22(2):165-72. doi: 10.1007/s40292-015-0091-6. Epub 2015 Apr 22.
6
Calcium channel blockers in cardiovascular pharmacotherapy.钙通道阻滞剂在心血管药物治疗中的应用。
J Cardiovasc Pharmacol Ther. 2014 Nov;19(6):501-15. doi: 10.1177/1074248414530508. Epub 2014 May 28.
7
High‑density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension.特发性肺动脉高压患者的高密度脂蛋白胆固醇水平与肺动脉血管反应性。
Pol Arch Intern Med. 2018 Aug 31;128(7-8):440-446. doi: 10.20452/pamw.4306. Epub 2018 Jul 27.
8
Role of Vasodilator Testing in Pulmonary Hypertension.血管扩张剂测试在肺动脉高压中的作用
Prog Cardiovasc Dis. 2016 Jan-Feb;58(4):425-33. doi: 10.1016/j.pcad.2015.09.006. Epub 2015 Oct 3.
9
Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.通过心肺运动试验评估钙通道阻滞剂对特发性肺动脉高压患者急性肺血管反应性试验阳性者的疗效。
Pulm Pharmacol Ther. 2017 Apr;43:26-31. doi: 10.1016/j.pupt.2017.01.012. Epub 2017 Feb 1.
10
Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy.基于证据的钙通道阻滞剂治疗高血压评估：相对于传统疗法的死亡率和心血管风险等同性。
J Am Coll Cardiol. 2002 Jan 16;39(2):315-22. doi: 10.1016/s0735-1097(01)01728-4.
本文引用的文献
1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
2
Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.肺动脉高压的诊断与治疗：综述
JAMA. 2022 Apr 12;327(14):1379-1391. doi: 10.1001/jama.2022.4402.
3
Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.特发性肺动脉高压中的关键基因组网络与血管反应性变异体
Am J Respir Crit Care Med. 2016 Aug 15;194(4):464-75. doi: 10.1164/rccm.201508-1678OC.
4
Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure.失代偿性肺动脉高压和右心室衰竭的医院及重症监护病房管理
Heart Fail Rev. 2016 May;21(3):323-46. doi: 10.1007/s10741-015-9514-7.
5
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015 ESC/ERS 肺动脉高压诊断与治疗指南：欧洲心脏病学会（ESC）和欧洲呼吸学会（ERS）肺动脉高压诊断与治疗工作组制定：该指南得到了欧洲儿科和先天性心脏病协会（AEPC）以及国际心肺移植学会（ISHLT）的认可。
Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29.
6
Intensive care unit management of patients with severe pulmonary hypertension and right heart failure.严重肺动脉高压与右心衰竭患者的重症监护病房管理。
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1114-24. doi: 10.1164/rccm.201104-0662CI.
7
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.特发性肺动脉高压患者对钙通道阻滞剂的长期反应
Circulation. 2005 Jun 14;111(23):3105-11. doi: 10.1161/CIRCULATIONAHA.104.488486. Epub 2005 Jun 6.
8
Calcium channel blockers in primary pulmonary hypertension.钙通道阻滞剂与原发性肺动脉高压
Chest. 1985 Oct;88(4 Suppl):257S-260S. doi: 10.1378/chest.88.4_supplement.257s.
9
The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.高剂量钙通道阻滞剂对原发性肺动脉高压患者生存率的影响。
N Engl J Med. 1992 Jul 9;327(2):76-81. doi: 10.1056/NEJM199207093270203.
Zotero 插件